Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Platelet-rich plasma shows potential for hair growth, but more research is needed to determine the best preparation method.

Avicennia marina heartwood extract shows strong antioxidant potential for health benefits.

PRP injection therapy shows promise for treating hair loss, increasing hair count and thickness with minimal side effects.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

The compound was successfully made and shows potential for treating prostate cancer.

The patient has a rare skin condition that shows features of two known disorders.

The emulsion made from tea plant and onion extracts shows promise for treating hair loss.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Drinking kava tea can cause a skin reaction with red, swollen bumps, which may improve with steroids.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

PRP shows promise for hair growth, but more research and standardized protocols are needed.

The method shows hair testosterone levels reflect those in saliva, but are affected by various factors and may indicate a risk for heart attack.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

Metformin shows promise for treating skin conditions, but more research is needed.

PRP shows promise but lacks consistent evidence and regulation.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Peperomia pellucida shows promise for developing new therapeutic drugs.